Booting in

7 Feb 2006

The UK regulator has decided not to refer the chemist s merger with Alliance Unichem for a lengthy competition enquiry. That raises the bar for private equity groups plotting a counterbid. They will have to offer a big premium to stop the deal going ahead.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)